1000 mg, soft capsules
Omega-3 acid ethyl esters 90
Omacor contains highly purified omega-3 polyunsaturated fatty acids.
Omacor belongs to a group of medicines that lower cholesterol and triglyceride levels.
Omacor is used:
If any of the above statements apply to you, do not take the medicine and consult your doctor.
Before taking Omacor, discuss it with your doctor or pharmacist:
If you are taking medicines that prevent blood clots in arteries, such as warfarin, you may need to have additional blood tests and adjust the dose of blood-thinning medicines.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take.
Capsules should be taken during meals. This will help avoid stomach and gastrointestinal problems.
Caution should be exercised when using Omacor in people over 70 years old.
Omacor should not be used in children.
Omacor should not be used during pregnancy and breastfeeding, unless your doctor decides it is absolutely necessary.
Before taking any medicine, consult your doctor or pharmacist.
It is unlikely that Omacor will affect your ability to drive or use machines.
Omacor contains soybean oil. If you are allergic to peanuts or soy, do not take Omacor.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The usual dose is two capsules per day, as recommended by your doctor.
If the medicine does not work well enough, your doctor may increase the dose to four capsules per day.
Accidental overdose is unlikely to cause concern, as it usually does not require special treatment. However, consult your doctor or pharmacist.
If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. In this case, take the next dose at the scheduled time. Do not take a double dose (twice the dose recommended by your doctor) to make up for the missed dose.
If you have any doubts about taking the medicine, consult your doctor or pharmacist.
Like all medicines, Omacor can cause side effects, although not everybody gets them.
The following side effects may occur when taking Omacor:
If any of the side effects get worse or if you notice any side effects not listed in this leaflet, tell your doctor or pharmacist.
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Reporting side effects will help gather more information on the safety of the medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Do not store above 25°C. Do not freeze.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Omacor is omega-3 ethyl esters 90.
1000 mg of omega-3 ethyl esters 90 contains 460 mg of ethyl ester of eicosapentaenoic acid (EPA) and 380 mg of ethyl ester of docosahexaenoic acid (DHA) (these substances are called omega-3 polyunsaturated fatty acids), and as an antioxidant 4 mg of D-alpha-tocopherol (mixed with vegetable oil, e.g., soybean oil).
Capsule shell: gelatin, glycerol, purified water, medium-chain triglycerides, lecithin (soy).
Omacor is available in the form of transparent, soft capsules containing a light yellow oil.
The package contains 28 capsules.
For more detailed information, contact the marketing authorization holder or the parallel importer.
BGP PRODUCTS LTD
Ag. Dimitriou 63
174 56 Alimos
Greece
Pronova BioPharma Norge AS
Lilleakerveien 2 C
0238 Oslo
Norway
Pierre Fabre Medicament Production
Le Payrat
46000 Cahors
France
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in Greece, the country of export:3196/13-01-2009
Parallel import authorization number:242/13
Date of leaflet approval: 27.04.2023
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.